Year archive

Jacobio Pharmaceuticals Group Co., Ltd. — 2023 filings

All 52 regulatory filings released by Jacobio Pharmaceuticals Group Co., Ltd. (1167) in 2023, sourced directly from the official regulator.

52 Filings

2023 Period

2023 filings (52)

Filing	Released	Lang
NEXT DAY DISCLOSURE RETURN Share Issue/Capital Change	2023-12-22	English
VOLUNTARY ANNOUNCEMENT JACOBIO TO PRESENT CLINICAL DATA OF KRAS G12C INHIBITOR GLECIRASIB IN PATIENTS WITH PANCREATIC CANCER AND OTHER SOLID TUMORS AT THE 2024 ASCO GI Regulatory Filings	2023-12-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2023 Share Issue/Capital Change	2023-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2023 Share Issue/Capital Change	2023-11-02	English
VOLUNTARY ANNOUNCEMENT PRESENTATION OF CLINICAL DATA OF GLECIRASIB IN COMBINATION WITH JAB-3312 AT THE 2023 ESMO CONGRESS Regulatory Filings	2023-10-23	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2023 Transaction in Own Shares	2023-10-05	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2023-09-29	English
2023 INTERIM REPORT Interim / Quarterly Report	2023-09-28	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2023-09-26	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2023 Share Issue/Capital Change	2023-09-04	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2023-08-31	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-08-31	English
(1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023; (2) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND (3) CHANGE IN THE COMPOSITION OF THE NOMINATION COMMITTEE Interim / Quarterly Report	2023-08-30	English
DATE OF BOARD MEETING Report Publication Announcement	2023-08-18	English
VOLUNTARY ANNOUNCEMENT KRAS G12C INHIBITOR JAB-21822 (GLECIRASIB) WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR TREATMENT OF PANCREATIC CANCER BY THE CENTER FOR DRUG EVALUATION (CDE) OF THE NMPA Regulatory Filings	2023-08-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2023 Regulatory Filings	2023-08-03	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2023-07-25	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2023-07-24	English
VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2023-07-24	English
VOLUNTARY ANNOUNCEMENT JACOBIO TO PRESENT CLINICAL DATA OF GLECIRASIB IN COMBINATION WITH JAB-3312 AT THE 2023 ESMO CONFERENCE Regulatory Filings	2023-07-21	English
VOLUNTARY ANNOUNCEMENT ENTERING INTO THE CAPITAL INCREASE AGREEMENT Capital/Financing Update	2023-07-06	English
JACOBIO REGAINS GLOBAL RIGHTS TO SHP2 INHIBITORS Regulatory Filings	2023-07-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2023 Regulatory Filings	2023-07-03	English
VOLUNTARY ANNOUNCEMENT JACOBIO PRESENTS CLINICAL RESULTS OF GLECIRASIB IN COLORECTAL CANCER Regulatory Filings	2023-06-29	English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2023-06-08	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 8, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-06-08	English
VOLUNTARY ANNOUNCEMENT INVESTIGATIONAL NEW DRUG (IND) APPROVAL FOR PARP7 INHIBITOR JAB-26766 IN CHINA Regulatory Filings	2023-06-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2023 Regulatory Filings	2023-06-02	English
FORM OF PROXY FOR THE 2023 ANNUAL GENERAL MEETING AGM Information	2023-05-16	English
NOTICE OF 2023 ANNUAL GENERAL MEETING AGM Information	2023-05-16	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL G AGM Information	2023-05-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2023 Share Issue/Capital Change	2023-05-04	English
SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTION IN RELATION TO THE LEASE AGREEMENT Regulatory Filings	2023-04-25	English
2022 ANNUAL REPORT Annual Report	2023-04-25	English
VOLUNTARY ANNOUNCEMENT THE RESULTS OF THREE PRECLINICAL STUDIES PRESENTED AT THE AACR 2023 Regulatory Filings	2023-04-18	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2023 Regulatory Filings	2023-04-04	English
INVESTIGATIONAL NEW DRUG (IND) APPROVAL FOR LIF mAb JAB-BX300 IN CHINA Regulatory Filings	2023-04-04	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-03-22	English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2023-03-22	English
(1) CHANGE IN INDEPENDENT NON-EXECUTIVE DIRECTORS; AND (2) CHANGE OF COMPOSITION OF BOARD COMMITTEES Board/Management Information	2023-03-22	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 AND CHANGE IN USE OF PROCEEDS Annual Report	2023-03-22	English
VOLUNTARY ANNOUNCEMENT INVESTIGATIONAL NEW DRUG (IND) APPROVAL FOR GUE INHIBITOR JAB-24114 IN CHINA Regulatory Filings	2023-03-17	English
THE RESULTS OF THREE PRECLINICAL STUDIES WILL BE PRESENTED AT THE AACR 2023 Regulatory Filings	2023-03-14	English
VOLUNTARY ANNOUNCEMENT STATEMENT RELATED TO SILICON VALLEY BANK Regulatory Filings	2023-03-12	English
CONNECTED TRANSACTION VARIATION OF TERMS TO PURCHASE OF SERIES A SHARES IN HEBECELL (AS SUPPLEMENTED AND AMENDED BY THE SUPPLEMENTAL AGREEMENT) Capital/Financing Update	2023-03-10	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-10	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2023 Share Issue/Capital Change	2023-03-02	English
NEXT DAY DISCLOSURE RETURN Share Issue/Capital Change	2023-02-17	English
COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE Capital/Financing Update	2023-02-17	English
PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE Capital/Financing Update	2023-02-10	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2023 Regulatory Filings	2023-02-02	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2022 Regulatory Filings	2023-01-03	English